Bosulif (bosutinib) 500 mg, 28 film-coated tablets, Pfizer Deutschland Bosulif (bosutinib) is used for certain forms of chronic myeloid leukemia. International medicine delivery within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications
Bosulif is indicated for the treatment of adults with:
- newly diagnosed chronic myeloid leukemia (CML) with the presence of the Philadelphia chromosome (Ph+) in the chronic phase;
- chronic myeloid leukemia (CML) with the presence of the Philadelphia chromosome (Ph+) in the chronic phase, the acceleration phase or in blast crisis in case of intolerance or ineffectiveness of previous therapy.
-
Dozuvannya
First diagnosed Ph+ CML in the chronic phase
The recommended dose is 400 mg bosutinib once daily.
Ph+ CML in chronic phase, accelerated phase or blast crisis in case of intolerance or ineffectiveness of previous therapy
The recommended dose is 500 mg bosutinib once daily.
- Trade name:Bosulif
- Chemical name:Bosutinib
- Dosage:500 mg
- Quantity:28
- Dosage form:Tablets
- Manufacturer:Pfizer
No reviews yet
